Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Mathilde Kouwenhoven

Has grant

Neurologist

VU medisch centrum

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Medical Imaging Medical Imaging professors in Netherlands

Recent Grants

Grant: Close

Phase 1 trial: Hydroxyurea and temozolomide in recurrent glioblastoma

Open Date:

Close Date:

Articles (13)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (11)

Johan Koekkoek

Neurologist / Neuro-oncologist / Head of outpatient clinic

Leiden University Medical Center

NETHERLANDS

View details

Jacoline Bromberg

Researcher

Erasmus University Rotterdam

NETHERLANDS

View details

Martin Klein

University of Amsterdam

NETHERLANDS

View details

Alle Meije Wink

Assistant Professor

Amsterdam UMC Locatie VUmc

NETHERLANDS

View details

Eleonora Swart

Head of Department

Amsterdam UMC Locatie AMC

NETHERLANDS

View details

Henk Mutsaerts

Assistant prof

University of Amsterdam

NETHERLANDS

View details

Bart A Westerman

Associate Professor

VU medisch centrum

NETHERLANDS

View details

Imke H. Bartelink

NETHERLANDS

View details

Victor Thijssen

Associate Professor / Principal Investigator

Amsterdam University Medical Centers

NETHERLANDS

View details

Adrianus de Langen

The Netherlands Cancer Institute

NETHERLANDS

View details

Florien Boele

Associate Professor of Medical Psychology

University of Leeds

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mathilde Kouwenhoven

Research Interests

Explore related searches

Recent Grants

Articles (13)

Amsterdam IMAging and Clinical GliOma Dataset; IMAGO

Physiologically Based Pharmacokinetic Model of Tyrosine Kinase Inhibitors to Predict Target Site Penetration, with PET‐Guided Verification

Long-Term Follow-Up Results of Antiseizure Medication Withdrawal in Grade 2 and 3 Glioma Patients: A Prospective Observational Study.

Severe temozolomide-induced thrombocytopenia is linked to increased healthcare utilization in glioblastoma and disproportionally impacts female patients

Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4

Adverse health outcomes and health-related quality of life (HRQoL) among long-term adolescent and young adult (AYA) brain tumour survivors: results from the population-based SURVAYA study

A Real-world Toxicity Atlas Shows that Adverse Events of Combination Therapies Commonly Result in Additive Interactions

Medulloblastoma in adults

Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?

Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy

Frequency and burden of potentially treatable symptoms in glioma patients with stable disease

Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis

Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades

Collaborators (11)

Johan Koekkoek

Jacoline Bromberg

Martin Klein

Alle Meije Wink

Eleonora Swart

Henk Mutsaerts

Bart A Westerman

Imke H. Bartelink

Victor Thijssen

Adrianus de Langen

Florien Boele

Make your next move.